BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 12706646)

  • 1. The changing face of bioinformatics.
    Gatto JG
    Drug Discov Today; 2003 May; 8(9):375-6. PubMed ID: 12706646
    [No Abstract]   [Full Text] [Related]  

  • 2. Today's biotech industry in India.
    Suresh N
    Biotechnol J; 2009 Mar; 4(3):291-4. PubMed ID: 19296434
    [No Abstract]   [Full Text] [Related]  

  • 3. Whose genome is it anyway?
    Uhlén M
    Trends Biotechnol; 1995 May; 13(5):160-2. PubMed ID: 7786493
    [No Abstract]   [Full Text] [Related]  

  • 4. Overcoming the challenges in the pharma/biotech industry.
    Graul AI; Prous JR
    Drug News Perspect; 2007; 20(1):57-68. PubMed ID: 17332900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioinformatics--principles and potential of a new multidisciplinary tool.
    Benton D
    Trends Biotechnol; 1996 Aug; 14(8):261-72. PubMed ID: 8987456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. When the human genome project and state street collide.
    Locke SD; Kalow DA
    Nat Biotechnol; 2000 Sep; 18(9):1009-10. PubMed ID: 10973226
    [No Abstract]   [Full Text] [Related]  

  • 7. Genomic sciences and the medicine of tomorrow.
    Drews J
    Nat Biotechnol; 1996 Nov; 14(11):1516-8. PubMed ID: 9634812
    [No Abstract]   [Full Text] [Related]  

  • 8. The power of genomics to transform the biotechnology industry.
    Haseltine WA
    Nat Biotechnol; 1998 May; 16 Suppl():25-7. PubMed ID: 9591259
    [No Abstract]   [Full Text] [Related]  

  • 9. Break with tradition.
    Jayaraman KS
    Nature; 2006 Jul; 442(7101):342-3. PubMed ID: 16871181
    [No Abstract]   [Full Text] [Related]  

  • 10. Biotech industry tries to recover from 2-year lull.
    Brower V
    J Natl Cancer Inst; 2003 Mar; 95(5):348-9. PubMed ID: 12618496
    [No Abstract]   [Full Text] [Related]  

  • 11. Advances in genome biology and technology.
    Mardis ER
    Pharmacogenomics; 2004 Jun; 5(4):355-6. PubMed ID: 15165171
    [No Abstract]   [Full Text] [Related]  

  • 12. Overcoming the obstacles in the pharma/biotech industry: 2008 update.
    Graul AI; Revel L; Rosa E; Cruces E
    Drug News Perspect; 2009; 22(1):39-51. PubMed ID: 19209298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patent threat in emerging economies shifts to biotech.
    Jayaranam K
    Nat Biotechnol; 2008 May; 26(5):481-3. PubMed ID: 18464760
    [No Abstract]   [Full Text] [Related]  

  • 14. The case for entrepreneurship in R&D in the pharmaceutical industry.
    Douglas FL; Narayanan VK; Mitchell L; Litan RE
    Nat Rev Drug Discov; 2010 Sep; 9(9):683-9. PubMed ID: 20725093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of the private sector in biotechnology: research and development.
    Feisee L
    Health Matrix Clevel; 2002; 12(2):357-65. PubMed ID: 12430359
    [No Abstract]   [Full Text] [Related]  

  • 16. US personalized-medicine industry takes hit from Supreme Court.
    Ledford H
    Nature; 2016 Aug; 536(7617):382. PubMed ID: 27558042
    [No Abstract]   [Full Text] [Related]  

  • 17. Reinventing an industry.
    Mandavilli A
    Nature; 2007 Jan; 445(7124):138-9. PubMed ID: 17215817
    [No Abstract]   [Full Text] [Related]  

  • 18. Bioentrepreneurship 2002: at home in your lab.
    Eisenhardt PE
    Anal Bioanal Chem; 2002 Jan; 372(1):9-11. PubMed ID: 11939216
    [No Abstract]   [Full Text] [Related]  

  • 19. Patenting of genetic material: are the benefits to society being realized?
    Willison DJ; MacLeod SM
    CMAJ; 2002 Aug; 167(3):259-62. PubMed ID: 12186174
    [No Abstract]   [Full Text] [Related]  

  • 20. Biotech reels over patent ruling.
    Check-Hayden E
    Nature; 2014 Jul; 511(7508):138. PubMed ID: 25008505
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.